KUWAIT DRUGS

 

SEARCH

 

SUGGESTIONS

 

ADD PRODUCTS

 

HOME

0-9    A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

 

 

PREVIOUS

  

NEXT

 
 

FOLITAB 1 MG TABLETS

 

 
 

 

GENERIC NAMES

MANUFACTURERS 

MEDICAL GROUP

MEDICAL ARTICLES

 

DRUGS IN :

 

 

FDA DRUGS

UNITED STATES

CANADA

UNITED KINGDOM

AUSTRALIA

GERMANY

FRANCE

MIDDLE EAST

KUWAIT

LEBANON

EGYPT

SYRIA

BAHRAIN

IRAN

JORDAN

SAUDI ARABIA

UNITED ARAB EMIRATES

 

 

 
 

SIZE:

1 MG

 

GENERIC NAME:

FOLIC ACID

 

MANUFACTURER:

KSPICO

 

UNIT:

 

ADMINISTRATION ROUTE:

 

FDA PREGNANCY GROUP:

A

 

INDICATIONS:

Anemia, megaloblastic

 

SIDE EFFECTS:

Allergic reaction, specifically

bronchospasm

erythema

fever

general malaise

skin rash or itching

 

ABSOLUTE CONTRAINDICATIONS :

 

RELATIVE CONTRAINDICATIONS :

>> Pernicious anemia

 

ADULT DOSE:

Deficiency (prophylaxis)-Oral, amount based on normal daily recommended intakes: Persons U.S. Canada (mcg) (mcg) Adolescent and adult males 150-400 150-220 Adolescent and adult females 150-400 145-190 Pregnant females 400 to 800 445-475 Breast-feeding females 260-800 245-275 Deficiency (treatment)-Treatment dose is individualized by prescriber based on severity of deficiency. [Diagnostic aid (folate deficiency)] -Oral, 100 to 200 mcg (0.1 to 0.2 mg) a day for ten days plus low dietary folic acid and vitamin B .

 

MAXIMUM ADULT DOSE:

 

PEDIATRIC DOSE:

Deficiency (prophylaxis)-Oral, amount based on normal daily recommended intakes: Persons U.S. Canada (mcg) (mcg) Infants and children 25- 50-80 Birth to 3 years of age 4 to 6 years of age 75-400 90 7 to 10 years of age 100-400 125-180 Deficiency (treatment)-Treatment dose is individualized by prescriber based on severity of deficiency. 

 

MAXIMUM PEDIATRIC DOSE:

 

ELDERLY DOSE:

 

 

PREVIOUS

  

NEXT